What Changed in TRXF11’s R$ 340 Million Transaction?
Yes, the fund finalized the transaction. The material fact released on 09/24/2026 details the completion of the corporate building purchase and sale commitments initially announced on September 11, 2026, totaling exactly R$ 340,250,163.03 invested in corporate slab assets.
The major development reshaping the deal is the use of a third-party designation clause: instead of holding the properties directly in its retail and urban income portfolio, the TRXF11 real estate fund (FII) designated the newly created Hedge Renda Corporativa FII (HRCO) to take on the final buyer position entirely. As a result, TRXF11 now holds units in this new investment vehicle, remodeling how these office assets enter the structure.
How Did TRXF11 Pay This Million-Real Bill?
The financial engineering combined credit compensation with newly issued units and very long-term installment payments. To settle part of the R$ 340.25 million, the fund used the subscription and capitalization of units from its 13th unit issuance, executed through credit compensation with the selling funds HAAA11 and HOFC11.
The remainder was split into substantial final installments maturing on October 20, 2033: R$ 154,007,000.00 related to the Thera property and R$ 25,308,000.00 concerning HOFC. This remaining balance will be adjusted by inflation via the IPCA plus a rate of 9.20% per year, with credit assignment permitted under a true sale arrangement. Meanwhile, transfer taxes (ITBI) and structural costs were borne entirely by the selling funds.
Which Corporate Assets Make Up the R$ 340.25 Million Package?
The package acquired and transferred to HRCO is concentrated in strategic locations across São Paulo and comprises the Thera Property—specifically units 31, 32, 41, 42, 161, 162, 171, 172, 181, and 182 located in the Thera Corporate Sub-condominium (Tower 3)—the usufruct over the Morumbi Building, and units in HOFC Empreendimentos.
These assets represent a meaningful venture by the management group into the high-end corporate slab market, a segment quite distinct from the traditional grocery and big-box retail thesis that forms the bulk of TRXF11's revenue. By passing them on to HRCO, management avoids mixing the operational dynamics of office slabs with the fund's primary urban retail portfolio traded on the B3.
What Is the Impact on Current Market Price and Monthly Dividends?
For investors tracking the fund's market price and assessing whether it is worth buying, the move provides important tactical relief by using the 13th issuance itself as a payment instrument, mitigating immediate cash needs. With units trading at R$ 73.99 (compared to a book value per unit of R$ 96.62, yielding a price-to-book ratio of 0.77), unitholders are closely monitoring how these restructurings impact monthly dividends.
The distributed dividend has remained stable at R$ 0.93 per unit, delivering an annualized dividend yield of roughly 12.7%. The structuring of HRCO and the deferred installments running through October 2033 relieve short-term cash flow pressure on TRXF11, allowing capital from the 13th issuance to be allocated gradually without sacrificing the predictability of recurring distributions paid to retail unitholders.
What to Watch in TRXF11’s Upcoming Management Reports
Upcoming earnings releases and the management report will provide crucial updates on the maturation of Hedge Renda Corporativa FII (HRCO) and the progress of the 13th unit issuance. Unitholders should monitor:
- Progress of the 13th issuance: The fundraising pace and success in placing new units to cover outstanding financial commitments.
- HRCO performance: How the new corporate fund generates revenue from the Thera and Morumbi properties and the liquidity of these units within TRXF11's portfolio.
- Long-term liabilities: The performance of the debt tied to IPCA + 9.20% per year, maturing in October 2033.
The Verdict: Hold or Adjust Position?
TRXF11 demonstrates flexibility in managing its expansion pipeline by offloading corporate assets to a dedicated vehicle (HRCO) and funding the transaction with units from its ongoing offering. For anyone evaluating whether the fund is worth it, the retail-focused urban income thesis remains solid, now supported by corporate engineering that shields the main cash flow from excessive short-term pressure.
